Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v1-EN
Language French English
Date Updated 2020-01-03 2019-12-17
Drug Identification Number 02309238 02309238
Brand name BREVIBLOC PREMIXED INJECTION BREVIBLOC PREMIXED INJECTION
Common or Proper name esmolol hydrochloride esmolol hydrochloride
Company Name BAXTER CORPORATION BAXTER CORPORATION
Ingredients ESMOLOL HYDROCHLORIDE ESMOLOL HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 units/case (CA2J1415) 10 units/case (CA2J1415)
ATC code C07AB C07AB
ATC description BETA BLOCKING AGENTS BETA BLOCKING AGENTS
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date 2019-12-17 2019-12-17
Actual start date 2019-12-17 2019-12-17
Estimated end date 2020-01-02 2020-01-06
Actual end date 2020-01-02
Shortage status Resolved Anticipated shortage
Company comments Baxter product BREVIBLOC Injection esmolol hydrochloride Solution, 10 mg/mL (100 mg/10 mL Vials) (DIN: 02188880) is available as an alternative if it aligns with clinical practice. Baxter product BREVIBLOC Injection esmolol hydrochloride Solution, 10 mg/mL (100 mg/10 mL Vials) (DIN: 02188880) is available as an alternative if it aligns with clinical practice.
Health Canada comments